Automatic Sign Language Translation for Healthcare Websites
Automatic Sign Language Translation for Healthcare Websites
批准号:
10044419
负责人:
金额:
$4.91万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There are approximately 87,000 people who use British Sign Language (BSL) daily in the UK. Only 1% of websites are considered accessible to these people (RNID, 2018). Deaf people often have poor literacy rates and struggle to understand written English. The traditional solution is to use a BSL Interpreter to enable Deaf people to understand important information. However, there are only 1000 interpreters in the UK; meaning a lengthy wait for interpretation of about two days on average. The result is a communication barrier between public services and Deaf people that need access to information, with a particular struggle with healthcare. Research has shown that Deaf people's health is already much poorer than hearing people's, with accessibility to information a major factor in this (SignHealth, 2020). Accessibility is even lower online, with almost no examples of signed content on healthcare websites. The main reason is the cost of hiring interpreters to sign all the content, with a £180 an hour translation cost infeasible. In this project, Signapse will scope the feasibility of building automatic sign language translation technology for healthcare websites. Backed by 20 years of computational research, Signapse's mission is to bring AI and sign language together. Signapse was founded after being approached by major organisations that wanted a real-time and cheaper alternative to BSL interpreters. We have developed world-leading innovative technology that is well received by the Deaf community. Our next development phase is to investigate innovative translation methodologies for constrained domains such as healthcare. Healthcare websites are an ideal place to develop our translation technology, as it is both a useful application but also a constrained domain which requires less data to tackle. Within the proposed project, we shall conduct a feasibility study to assess the requirements of the technology, understand the task and enable a commercialisation plan for the market. Due to the large degree of innovation involved with this technology, we believe it is important to first scope the market before we catalyse further innovation on our path to commercial success. If this project is successful, it will enable more accessibility for Deaf people online, meaning they can better understand healthcare content and access self help materials online, particularly pertaining to mental health and wellbeing. This will increase their ability to perform self-care, without relying on human interpretation. We believe this project will significantly improve the health of all BSL users.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于BCG载药系统靶向抑制DC-SIGN阳性肿瘤相关巨噬细胞增强脾胱癌免疫治疗的应用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘康
-
依托单位:
局灶节段硬化性肾小球肾炎中FSTL3通过DC-SIGN促足细胞凋亡的作用研究
-
批准号:82300796
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:林力
-
依托单位:
DC-SIGN阳性肿瘤相关巨噬细胞通过诱导Th22细胞亚群分化促进膀胱癌免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:许乐
-
依托单位:
DC-SIGN+肿瘤相关巨噬细胞发生及促肌层浸润性膀胱癌免疫逃逸的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:胡宝英
-
依托单位:
DC-SIGN/R靶向糖纳米抑制剂开发及结构机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:
-
依托单位:
RORγt+调节性T细胞参与DC-SIGN+肿瘤相关巨噬细胞介导的胃癌免疫逃逸过程的作用和机制研究
-
批准号:82003019
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:李鹤
-
依托单位:
RA成纤维样滑膜细胞DC-SIGN在B细胞活化中的作用及其临床意义
-
批准号:82001742
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:石茂华
-
依托单位:
LeX检查点通过DC-SIGN信号轴介导T细胞抑制和肿瘤浸润促进白血病免疫逃逸的机制研究
-
批准号:32060218
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2020
-
负责人:李红
-
依托单位:
CSF-1诱导的DC-SIGN+巨噬细胞在子宫内膜异位症免疫抑制过程中的作用
-
批准号:81801417
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:安敏
-
依托单位:
DC-SIGN介导的免疫调控在真菌性角膜炎发病机制中的研究
-
批准号:81870632
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:赵桂秋
-
依托单位: